Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort

BACKGROUND: Standard clinical parameters cannot accurately differentiate indolent from aggressive prostate cancer. Our previous work showed that immunohistochemical (IHC) Ki-67 improved prediction of prostate cancer death in a cohort of conservatively treated clinically localised prostate cancers di...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fisher, G, Yang, Z H, Kudahetti, S, Møller, H, Scardino, P, Cuzick, J, Berney, D M
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2013
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566811/
https://ncbi.nlm.nih.gov/pubmed/23329234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.598
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars